Shilpa Medicare Bengaluru facility gets registered with Ministry of Health, UAE

The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements.

Published On 2023-02-18 04:30 GMT   |   Update On 2023-02-18 04:31 GMT

Karnataka: Shilpa Medicare has recently announced that the company’s Bengaluru facility has been successfully registered with the Ministry of Health, United Arab Emirates, for manufacturing and testing of Orodispersible films and Transdermal systems. This registration enables company to register the products (Orodispersible films and Transdermal systems) in UAE for...

Login or Register to read the full article

Karnataka: Shilpa Medicare has recently announced that the company’s Bengaluru facility has been successfully registered with the Ministry of Health, United Arab Emirates, for manufacturing and testing of Orodispersible films and Transdermal systems.

 This registration enables company to register the products (Orodispersible films and Transdermal systems) in UAE for commercialization.

The facility is involved in manufacturing and testing of specialized dosage forms eg. Orodispersible Films and Transdermal systems. The facility is backed up with strong Research and Development of Orodispersible films and transdermal technologies.

The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements. The facility has already been issued GMP by UK MHRA. The facility also manufactures dietary supplements in orodispersible films and was registered with US FDA Food Facility registry. The facility is actively exporting dietary supplements to US Market.

Read also: Shilpa Medicare unveils Capecitabine 1000 MG dispersible tablet for breast cancer

Shilpa Medicare Limited started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India.

The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets.

Read also: Shilpa Medicare gets Health Canada GMP approval for Jadcherla facility

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News